NCT01759485View on ClinicalTrials.gov

Vitamin D for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

February 28, 2017

Conditions
Clozapine Resistant Schizophrenia
Interventions
DRUG

Vitamin D3

once weekly oral drops preparation at a daily dose of 2000 IU X 7 = 14,000 IU per week (about 60 drops each week).

DRUG

placebo

Trial Locations (1)

45000

Geha Mental Health Center, Petah Tikva

All Listed Sponsors
lead

Geha Mental Health Center

OTHER

NCT01759485 - Vitamin D for Schizophrenia | Biotech Hunter | Biotech Hunter